Larimar Therapeutics Revenue, Growth & Competitor Profile

DBA ZAFGEN, INC.

Company Profile & Annual Report for Larimar Therapeutics

Access the complete profile.

Larimar Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	5417 Scientific Research & Development Services
Address	Three Bala Plaza East Suite 506 Bala Cynwyd, PA 19004

Note: Revenues for privately held companies are statistical evaluations.


Larimar Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Larimar Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Larimar Therapeutics is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Larimar Therapeutics Annual Revenue and Growth Rate

Larimar Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Larimar Therapeutics's revenues are gauged from an analysis of company filings.

Larimar Therapeutics's Income Statement (based on Industry Averages)

Larimar Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Larimar Therapeutics is developing and marketing. Larimar Therapeutics doesn't have any recent trademark applications, indicating Larimar Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
LARIMAR THERAPEUTICS Pharmaceutical preparations for the treatment of mitochondrial disorders; Pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia; pharmaceutical preparations for protein replacement therapy	07/17/2020
DEDICATED TO THE TREATMENT OF OBESITY Medical and scientific research in the field of obesity; Medical research; Pharmaceutical research and development	08/09/2013

See all trademarks and details in the Full Report.

Market Share of Larimar Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Larimar Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Larimar Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
JUBILANT PHARMA HOLDINGS	Yardley, PA	100
SIGMAPHARM LABORATORIES	Bensalem, PA	8
OPTINOSE US	Yardley, PA	7
ZYLA LIFE SCIENCES	Wayne, PA	4
PHARMA RESOURCE GROUP	Drexel Hill, PA	4
COVEX	Wayne, PA	3

Other Companies at Three Bala Plaza East, Bala Cynwyd PA

Company	Headquarters	Revenue ($ MM)
MAGUIRE INSURANCE AGENCY	Bala Cynwyd, PA	100
GBLI HOLDINGS	Bala Cynwyd, PA	24
TMNA SERVICES	Bala Cynwyd, PA	6
BG CAPITAL	Bala Cynwyd, PA	1
BTB GROUP	Bala Cynwyd, PA	0

Future Competition: Larimar Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Larimar Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)